ADMA Biologics, Inc. (ADMA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

ADMA Biologics, Inc. (ADMA) closed at USD 10.34 on 2026-10-14, a change of -33.6 % over the past year, with a market capitalization of USD 2.4B.

ADMA Biologics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ADMA Biologics, Inc. key figures

Previous close

USD 10.34 (2026-10-14)

1-year change

-33.6 %

Market cap

USD 2.4B

Enterprise value

USD 2.47B

P/E ratio (trailing)

14.70

P/E ratio (forward)

11.38

EPS (trailing)

0.73

EPS (forward)

0.94

PEG ratio

n/a

Price to book

5.92

Revenue growth

2 %

Earnings growth

14.3 %

Dividend per share (trailing)

0.00

Short ratio

7.00

Employees

640

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ADMA Biologics, Inc.

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ADMA Biologics, Inc. and compare it with other stocks.